🔎 Trials Near Me

Home › Kanser ng Endometrium › Missouri

Pag-aaral pangklinika para sa Kanser ng Endometrium sa Missouri

31 pag-aaral para sa Kanser ng Endometrium ang naghahanap ng mga kalahok sa mga site sa Missouri.

Mga Lungsod sa Missouri

Opisyal na teksto ng pag-aaral (English)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Saint Francis Medical Center, Cape Girardeau
  • Saint Luke's Hospital, Chesterfield
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • at 13 pa
Nagre-recruitPhase 2
Lahat ng edad · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05564377

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • Washington University Medicine, St Louis
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06270706

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  • MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia
  • Mercy Hospital Springfield, Springfield
  • CoxHealth South Hospital, Springfield
  • at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Okt 2, 2026 · NCT07198074

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Washington University, School of Medicine, St Louis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06172478

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

  • MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia
  • Washington University School of Medicine, St Louis
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Set 28, 2026 · NCT05112601

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

  • Research Site, St Louis
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06218914

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

  • Washington University School of Medicine, St Louis
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Set 24, 2026 · NCT05640999

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • Washington University, St Louis
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07114601

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • Washington Univ. School of Medicine, St Louis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07109726

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

  • Research Site, St Louis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05123482

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  • Washington University School of Medicine, St Louis
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Set 9, 2026 · NCT07166094

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

  • Washington University School of Medicine - Siteman Cancer Center, St Louis
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07383506

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Washington University School of Medicine, St Louis
Nagre-recruitPhase 1/2
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • Washington University, Siteman Cancer Center, St Louis
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT06774963

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

  • HCA Midwest, Kansas City
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Ago 21, 2026 · NCT05548296

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

  • Normunity Investigational Site, St Louis
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07182149

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Washington University School of Medicine, St Louis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05919264

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Washington University, St Louis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT04657068

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

  • Investigative Site #110, St Louis
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT06974110

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

  • 334, Kansas City
  • 521, St Louis
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Hul 16, 2026 · NCT06906341

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • Saint Luke's Cancer Institute, Kansas City
  • Washington University, St Louis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT05768139

Integrated Cancer Repository for Cancer Research

  • Saint Luke's Cancer Institute, East, Kansas City
  • Saint Luke's Cancer Institute, Kansas City
  • Saint Luke's Cancer Institute, Kansas City North, Kansas City
  • at 3 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

  • Mercy Hospital - SPG, Springfield
  • Mercy Hospital - South, St Louis
  • Mercy Hospital -STL, St Louis
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT07327489

A Study of LY4175408 in Participants With Advanced Cancer

  • Washington University, St Louis
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT07046923

Uterine Preservation Via Lifestyle Transformation

  • Washington University School of Medicine, St Louis
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Ene 20, 2026 · NCT05903131

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

  • Washington University Medical Campus, St Louis
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 17, 2025 · NCT05856981

Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

  • Washington University School of Medicine, St Louis
Nagre-recruitPhase 1
Edad 18 pataas · Kababaihan · Na-update Dis 11, 2025 · NCT06795009

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Kansas City
  • Massive Bio SYNERGY-AI site, St Louis
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Mindfulness in Endometrial and Cervical Cancer

  • Saint Louis University, St Louis
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 90 · Kababaihan · Na-update Set 30, 2025 · NCT04512144

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

  • Washington University School of Medicine, St Louis
Nagre-recruitPhase 2/3
Edad 18 pataas · Kababaihan · Na-update May 2, 2024 · NCT05797831

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.